摘要
糖尿病肾病是糖尿病最主要的微血管并发症之一,它是导致慢性肾衰竭发生的主要原因,这种趋势在我国也越来越明显。糖尿病与高血压常合并存在。流行病学调查显示,在糖尿病人群中,高血压发生率比年龄匹配的非糖尿病人群高1.5-3倍。
出处
《内科急危重症杂志》
2014年第4期223-226,共4页
Journal of Critical Care In Internal Medicine
参考文献22
-
1KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease [ J ]. Am J Kidney Dis ,2007,49 ( 2 suppl 2 ) : S12-S154.
-
2Bakris GL,Weir MR,Shanifar S,et al. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL Study [ J ]. Arch Intern Med,2003,163 ( 13 ) : 1555-1565.
-
3Shankar A, Klein R, Klein BE. Relationship between low-normal blood pressure and kidney disease in type 1 diabetes. Hypertension [ J ]. 2007,49( 1 ) :48-54.
-
4UKPDS:UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38[J]. BMJ. 1998,317(7160) :703-713.
-
5Staessen JA, Fagard R,Thijs L,et al. Randomised double-blind com- parison of placebo and active treatment for older patients with isolated systolic hypertension The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. [ J ]. Lancet, 1997,350 (9080) :757-764.
-
6Bakris GL,Williams M,Dworkin L,et al. Preserving renal function in a- dults with hypertension and diabetes : a consensus approach. National kid- ney foundation hypertension and diabetes executive committees working group[J]. Am J Kidney Dis,20O,36(3):6464561.
-
7Bakris GL, Sowers JR. American Society of Hypertension Writing Group, ASH position paper: treatment of hypertension in patients with diabetes-an update[ J]. J Clini Hypertens ,2008,10(9 ) : 707-713.
-
8American Diabetes Association, Standards of Medical Care in Diabe- tes-2009 [ J ]. Diabetes Care January, 2009,32 ( suppl 1 ) : S 13 -S61.
-
9KDIGO BP Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease [ J ]. Kidney Int Supp1,2012,2(5) :337414.
-
10James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults report from the panel members appointed to the Eighth Joint National Committee (JNC 8),2014,311 (5):507-520.
同被引文献41
-
1刘志红.糖尿病肾病的治疗[J].中国实用内科杂志,2006,26(3):322-323. 被引量:102
-
2Reidy K, Kang HM, Hostetter T, et al. Molecular mechanisms of dia- betic kidney disease [ J ]. J Clin Invest,2014,124 ( 6 ) :2333-2340.
-
3Opelz G, Dohler B. Renin-Angiotensin system blockers and cardiovas- cular death in kidney recipients [ J ]. Transplantation. 2014,97 ( 1 ) : 62-63.
-
4Ortiz-Melo DI, Spunley RF. Special deLIVERy: podocyte injury pro- motes renal angiotensin II generation from liver-derived angiotensino- gen [ J ]. Kidney Int ,2014,85 ( 5 ) : 1009-1011.
-
5Wanitchanont A,Somparn P, Vadcharavivad S, et al. Effects of atorv- astatin on the pharmacokinetics of everolimus among kidney transplant recipients[J]. Transplant Proc,2014,46(2) :418-421.
-
6Huo X, Liu Q, Wang C, et al. Inhibitory effect of valsartan on the in- testinal absorption and renal excretion of bestatin in rats [J]. J Pharm Sci,2014,103 (2) :719-729.
-
7郭丽.糖尿病肾病性高血压的发病机制研究进展[J].中国保健营养,2013,23(11):7009-7010.
-
8Sun L,Zhang D,Liu F,et al. 1,ow-dose paclitaxcl ameliorates fibrosis in the remnant kidney model |/5, down-regnlaling miR-192 [ J ]. J Pathol, 2011,225 ( 3 ) : 364-377.
-
9Zhcng C, Li X, Kong C ,et al. Effect of single nucleotide tolymorphisnl in ttlrombin-activatable fibrinolysis inhibitor on lhe risk of diabetic macrovascular disease[ J ]. Blood Coagul Fibrinolysis, 2015,26 ( 2 ) : 185-190.
-
10Xu CW, Wu XB, Ma XL, eta]. Genetic variation in thromlin-aetivat- able fibrinolysis inhibitor is associated with tile risk of diabetic ne- phrofathy [ J ]. J Endocrinol Invest ,2012,35 ( 7 ) :620-624.
引证文献6
-
1苏海燕,蒋敏.阿托伐他汀联合缬沙坦和依那普利治疗高血压肾病的临床疗效分析[J].内科急危重症杂志,2015,21(2):122-124. 被引量:53
-
2郑洪涛.联合用药对糖尿病肾病伴高血压患者的临床疗效[J].糖尿病新世界,2016,19(15):10-11. 被引量:4
-
3王亚兰,郑承红,孔彩霞.TAFI在2型糖尿病肾病肾损伤发病机制中的作用[J].内科急危重症杂志,2016,22(4):305-307. 被引量:5
-
4谢丽平.连续性肾脏替代治疗在慢性肾病合并重症细菌性肺炎中的疗效[J].北方药学,2017,14(11):190-191. 被引量:2
-
5冯显.中西医治疗糖尿病肾病的研究概况[J].中国民族民间医药,2022,31(11):46-49. 被引量:6
-
6左立莹,赵玮,徐珊珊,王凯旋.降压药物在肾脏疾病中的应用效果分析[J].世界最新医学信息文摘,2016,16(68).
二级引证文献70
-
1张飞,陈翠玲,刘俏贤,袁圣亮.阿托伐他汀钙片辅助治疗高血压肾病的效果和安全性观察[J].智慧健康,2021,7(7):132-134. 被引量:2
-
2程光辉,谢芳,黄尾平,张劲林,韩宏伟.强化辛伐他汀对急性冠脉综合征合并慢性肾功能不全患者肾功能的影响[J].内科急危重症杂志,2020,0(1):25-28. 被引量:10
-
3杨世明.缬沙坦联合阿托伐他汀对早期糖尿病肾病的治疗疗效观察[J].糖尿病天地,2018,15(9):20-20. 被引量:2
-
4胡宝霞.评价阿托伐他汀钙联合缬沙坦治疗原发性高血压的效果及对血压和血脂水平的影响[J].中国实用医药,2018,13(36):128-129. 被引量:9
-
5龚豪,黄丽,张庆红,李涛,史秀岩.高血压肾病患者症状困扰与心理弹性和应对方式的相关性[J].中国健康心理学杂志,2019,27(1):68-71. 被引量:10
-
6魏丽波.前列地尔注射液治疗高血压性肾损害的疗效观察[J].中西医结合心血管病电子杂志,2015,3(28):45-46.
-
7秦利强,张卓,徐智,张敏.阿托伐他汀联合依那普利及缬沙坦对慢性肾炎患者尿素氮、血脂及炎症因子的影响[J].中国老年学杂志,2016,36(10):2470-2472. 被引量:37
-
8操轩,杨定平.早期糖尿病肾病血糖波动对尿微量白蛋白及炎症因子水平的影响[J].海南医学院学报,2016,22(20):2390-2392. 被引量:31
-
9宋晓英.缬沙坦联合依那普利对慢性心力衰竭患者心功能及BNP水平的影响[J].河南医学研究,2016,25(11):1954-1955. 被引量:2
-
10周欣满.缬沙坦治疗轻中度高血压疗效及安全性评价[J].中国药业,2016,25(23):50-53. 被引量:4
-
1孟华,张新芝.甲状腺功能亢进与心律失常[J].中国中医药现代远程教育,2010(15):164-164. 被引量:3
-
2何燕武,林建军,陈海敏.慢性阻塞性肺疾病急性加重期患者D-二聚体及C-反应蛋白定量检测的意义[J].中国初级卫生保健,2013,27(6):128-130. 被引量:4
-
3乔洁,李敬涛,曲桂一.133例甲亢患者心电图分析[J].中国实用医药,2015,10(5):38-39. 被引量:2
-
4庞晓玲.120例甲状腺功能亢进患者心电图分析[J].中国疗养医学,2015,24(5):492-493.
-
5高敏.甲状腺机能亢进患者的心电图分析[J].临床心电学杂志,2008,17(5):371-372. 被引量:10
-
6曲英秋.170例甲状腺机能亢进患者的心电图解析[J].当代医学,2009,15(31):10-10. 被引量:1
-
7张雪杰.糖尿病患者80例心电图分析[J].实用心电学杂志,2011,20(2):110-111. 被引量:1
-
8王磊,王敏,董宏伟,张强,张薇薇.冠心病合并2型糖尿病患者冠状动脉造影结果分析[J].山东医药,2009,49(45):62-63. 被引量:2
-
9朱定君,陈志强,夏鸿莉,李新花.未绝经女性与同年龄段男性冠心病患者临床特点及冠状动脉病变的对比分析[J].医学研究生学报,2011,24(11):1182-1184. 被引量:1
-
10石巧.代谢综合征患者血清抵抗素与胰岛素抵抗的关系[J].河北医药,2010,32(16):2189-2190. 被引量:1